Finance

Lists
Why is CAH up 3,35%?
Dive Deeper
CAH:NYSE
Cardinal Health, Inc
247,74 $
+3,35%
(+8,02) 1D
247,74 $
0,00% (0,00)
After hours
Closed: 14 հոկ, 16:00:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAH...
Open
240,90 $
High
247,93 $
Low
240,76 $
Mkt. cap
57,37 մլրդ
Avg. vol.
1,70 մլն
Volume
1,97 մլն
Dividend
0,83%
Quarterly dividend
0,52 $
Ex-dividend date
01 հոկ, 2026 թ.
P/E ratio
34,26
52-wk high
258,30 $
52-wk low
152,46 $
EPS
7,23 $
Beta
0,50
Shares outstanding
231,56 մլն
No. of employees
61 հզր
Open
240,90 $
High
247,93 $
Low
240,76 $
Mkt. cap
57,37 մլրդ
Avg. vol.
1,70 մլն
Volume
1,97 մլն
Dividend
0,83%
Quarterly dividend
0,52 $
Ex-dividend date
01 հոկ, 2026 թ.
P/E ratio
34,26
52-wk high
258,30 $
52-wk low
152,46 $
EPS
7,23 $
Beta
0,50
Shares outstanding
231,56 մլն
No. of employees
61 հզր
News stories
From web sources and news partners
Profile
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States. Wikipedia
About Cardinal Health, Inc
CEOJason Hollar
Employees61,3 հզր
Founded1971
HeadquartersDublin, Օհայո, Միացյալ Նահանգներ
SectorHealth care provider
Analyst ratings
Based on 14 analysts giving stock ratings to CAH in the past 3 months
Strong buy
Buy
12
Hold
2
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for CAH in the last 3 months.
Highest
Current 247,74 $
292,00 $ (+17,87%)
Average
270,00 $ (+8,99%)
Lowest
250,00 $ (+0,91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Buy
Maintained
276,00 $
+11,4%
10/12/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
277,00 $
+11,8%
09/09/2026
Glen Santangelo
Barclays
Buy
Reiterated
275,00 $
+11%
08/18/2026
Lisa Gill
J.P. Morgan
Hold
Maintained
260,00 $
+4,9%
08/17/2026
George Hill
Deutsche Bank
Hold
Maintained
261,00 $
+5,4%
08/13/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
250,00 $
+0,9%
08/13/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
280,00 $
+13%
08/13/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
270,00 $
+9%
08/12/2026
Erin Wright
Morgan Stanley
Buy
Maintained
255,00 $
+2,9%
08/12/2026
Daniel Grosslight
Citi
Buy
Maintained
280,00 $
+13%
08/12/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
277,00 $
+11,8%
08/12/2026
Michael Cherny
Leerink Partners
Buy
Maintained
292,00 $
+17,9%
08/11/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
08/11/2026
Allen Lutz
Bank of America Securities
Buy
Maintained
260,00 $
+4,9%
07/20/2026
Kevin Caliendo
UBS
Buy
Reiterated
274,00 $
+10,6%
07/20/2026
Unknown Analyst
William O'Neil
Buy
Initiated
-
-
06/12/2026
Unknown Analyst
Argus Research
Buy
Maintained
248,00 $
+0,1%
05/05/2026
Steven Silver
Argus Research
Buy
Maintained
248,00 $
+0,1%
05/05/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
248,00 $
+0,1%
05/01/2026
Max Smock
William Blair
Buy
Initiated
-
-
04/28/2026
Last report
11 օգս, 2026 թ.
Fiscal period
Q4 2026
2,60 $ / 2,42 $
+7,41%beat
Revenue / Est. (USD)
63,67 մլրդ / 65,11 մլրդ
-2,20%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
64,01 մլրդ
65,63 մլրդ
60,94 մլրդ
63,67 մլրդ
Cost of goods sold
61,69 մլրդ
63,23 մլրդ
58,44 մլրդ
61,11 մլրդ
Cost of revenue
61,69 մլրդ
63,23 մլրդ
58,44 մլրդ
61,11 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,46 մլրդ
1,50 մլրդ
1,54 մլրդ
1,62 մլրդ
Operating expense
1,55 մլրդ
1,59 մլրդ
1,64 մլրդ
1,71 մլրդ
Total operating expenses
63,24 մլրդ
64,82 մլրդ
60,08 մլրդ
62,82 մլրդ
Operating income
771,00 մլն
809,00 մլն
861,00 մլն
847,00 մլն
Other non operating income
10,00 մլն
11,00 մլն
-16,00 մլն
30,00 մլն
EBT including unusual items
598,00 մլն
630,00 մլն
392,00 մլն
554,00 մլն
EBT excluding unusual items
701,00 մլն
732,00 մլն
744,00 մլն
794,00 մլն
Income tax expense
144,00 մլն
159,00 մլն
12,00 մլն
154,00 մլն
Effective tax rate
24,08%
25,24%
3,06%
27,80%
Other operating expenses
-
-
-
-
Net income
450,00 մլն
467,00 մլն
399,00 մլն
398,00 մլն
Net profit margin
0,70%
0,71%
0,65%
0,62%
Earnings per share
2,55
2,63
3,17
2,60
Interest and investment income
-
-
-
-
Interest expense
-80,00 մլն
-88,00 մլն
-101,00 մլն
-103,00 մլն
Net interest expenses
-80,00 մլն
-88,00 մլն
-101,00 մլն
-103,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,00 մլրդ
1,04 մլրդ
1,11 մլրդ
1,09 մլրդ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps